A. Lambiase
Impact in
- Oncology top 5%
- Peptidase Inhibition and Analysis
- Cancer Treatment and Pharmacology
- HER2/EGFR in Cancer Research
- Colorectal Cancer Treatments and Studies
Papers in
- Oncology 49
- Peptidase Inhibition and Analysis 32
- Lung Cancer Research Studies 14
- Cancer Treatment and Pharmacology 10
-
- Advanced Breast Cancer Therapies 5
- Co-authors
- Claudio Bordignon (38 shared papers)Vanesa Gregorc (25 shared papers)Giovanni Citterio (15 shared papers)Armando Santoro (14 shared papers)Federico Caligaris‐Cappio (11 shared papers)Gilda Rossoni (13 shared papers)Luigi Mariani (2 shared papers)Emilio Bajetta (3 shared papers)
- Journals
- Journal of Clinical Oncology (24 papers)European Journal of Cancer (5 papers)Annals of Oncology (4 papers)British Journal of Cancer (4 papers)Breast Cancer Research and Treatment (3 papers)
- Partner nations
- ItalyUnited KingdomGermany
In The Last Decade
A. Lambiase
54 papers receiving 876 citations
Peers
Comparison fields: 5 of 58
- Oncology 538
- Immunology and Allergy 32
- Radiology, Nuclear Medicine and Imaging 113
- Biotechnology 43
- Pulmonary and Respiratory Medicine 144
Countries citing papers authored by A. Lambiase
This map shows the geographic impact of A. Lambiase's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Lambiase with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Lambiase more than expected).
Fields of papers citing papers by A. Lambiase
This network shows the impact of papers produced by A. Lambiase. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Lambiase. The network helps show where A. Lambiase may publish in the future.
Co-authors
The 25 scholars most cited alongside A. Lambiase, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 115 | |
| 2 | 2006 | 107 | |
| 3 | 2010 | 91 | |
| 4 | 2009 | 72 | |
| 5 | 2018 | 57 | |
| 6 | 2009 | 47 | |
| 7 | 2011 | 44 | |
| 8 | 2010 | 40 | |
| 9 | 2012 | 36 | |
| 10 | 2010 | 32 | |
| 11 | 2010 | 29 | |
| 12 | 2018 | 22 | |
| 13 | 2005 | 20 | |
| 14 | 2012 | 19 | |
| 15 | 2002 | 18 | |
| 16 | 2003 | 17 | |
| 17 | 2010 | 17 | |
| 18 | 2001 | 13 | |
| 19 | 2015 | 10 | |
| 20 | Capecitabine in association with epirubicin and docetaxel as first line chemotherapy in advanced breast cancer A dose-finding study | 2000 | 8 |
About A. Lambiase
A. Lambiase is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Epidemiology, Biotechnology and Cancer Research, having authored 55 papers that have together received 903 indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (32 papers), Lung Cancer Research Studies (14 papers), Neuroendocrine Tumor Research Advances (12 papers), Cancer Treatment and Pharmacology (10 papers), Cancer Research and Treatments (6 papers), Advanced Breast Cancer Therapies (5 papers), Hematopoietic Stem Cell Transplantation (4 papers) and Breast Cancer Treatment Studies (4 papers). The work is most often cited by research in Oncology (538 citations), Immunology and Allergy (32 citations), Radiology, Nuclear Medicine and Imaging (113 citations), Biotechnology (43 citations) and Pulmonary and Respiratory Medicine (144 citations). A. Lambiase has collaborated with scholars based in Italy, United Kingdom and Germany. Frequent co-authors include Claudio Bordignon, Vanesa Gregorc, Giovanni Citterio, Armando Santoro, Federico Caligaris‐Cappio, Gilda Rossoni, Luigi Mariani, Emilio Bajetta, Filippo de Braud and Johanna N.H. Timmer-Bonte. Their work appears in journals such as Journal of Clinical Oncology, European Journal of Cancer, Annals of Oncology, British Journal of Cancer and Breast Cancer Research and Treatment.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.